KPIs & Operating Metrics(New)
Breakdown Of AssetsContractual ObligationsCost Of SalesEmployee StatisticsGross Margin %Gross Margin Annual %Gross ProfitGross Profit AnnualIncome Before Income TaxesNon Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNon Gaap Profitability Annual %Operating Expense SegregationOpex As A % Of RevenueProperty, Plant & Equipment, Net BreakdownR&D As A %R&D SegregationRevenueRevenue By Customer TypeRevenue By Customer Type %Revenue By ProductRevenue By Product %Revenue By Product AnnualRevenue By Product Annual %Revenue By SegmentRevenue By Segment %
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Acadia Pharmaceuticals (ACAD) Gross Profit: 2009-2024

Historic Gross Profit for Acadia Pharmaceuticals (ACAD) over the last 16 years, with Dec 2024 value amounting to $876.0 million.

  • Acadia Pharmaceuticals' Gross Profit rose 10.99% to $257.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $962.5 million, marking a year-over-year increase of 13.07%. This contributed to the annual value of $876.0 million for FY2024, which is 27.91% up from last year.
  • As of FY2024, Acadia Pharmaceuticals' Gross Profit stood at $876.0 million, which was up 27.91% from $684.8 million recorded in FY2023.
  • Acadia Pharmaceuticals' 5-year Gross Profit high stood at $876.0 million for FY2024, and its period low was $431.5 million during FY2020.
  • Over the past 3 years, Acadia Pharmaceuticals' median Gross Profit value was $684.8 million (recorded in 2023), while the average stood at $689.3 million.
  • Data for Acadia Pharmaceuticals' Gross Profit shows a peak YoY soared of 35.05% (in 2023) over the last 5 years.
  • Yearly analysis of 5 years shows Acadia Pharmaceuticals' Gross Profit stood at $431.5 million in 2020, then increased by 7.75% to $465.0 million in 2021, then increased by 9.05% to $507.1 million in 2022, then soared by 35.05% to $684.8 million in 2023, then grew by 27.91% to $876.0 million in 2024.